Paper39512697
Decoding the Promise and Challenges of miRNA-Based Cancer Therapies: An Essential Update on miR-21, miR-34, and miR-155.
Qian H and 7 others. Int J Med Sci, 2024. Cited by 53 papers, by iCite.
Cite this record
ConductScience Library. Decoding the Promise and Challenges of miRNA-Based Cancer Therapies: An Essential Update on miR-21, miR-34, and miR-155. Papers, record 39512697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39512697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Decoding the Promise and Challenges of miRNA-Based Cancer Therapies: An Essential Update on miR-21, miR-34, and miR-155.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MicroRNAs | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Gene Expression Regulation, Neoplastic | |
| Precision Medicine |
Source PubMed
References118
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36815255 | The expression of Rab5 and its effect on invasion, migration and exosome secretion in triple negative breast cancer. | Korean J Physiol Pharmacol | 2023 | https://conductscience.org/library/papers/36815255 | PubMed |
| 2 | 36765409 | The various role of microRNAs in breast cancer angiogenesis, with a special focus on novel miRNA-based delivery strategies. | Cancer Cell Int | 2023 | https://conductscience.org/library/papers/36765409 | PubMed |
| 3 | 32238921 | Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. | Br J Cancer | 2020 | https://conductscience.org/library/papers/32238921 | PubMed |
| 4 | 23143100 | Differential activation and functional specialization of miR-146 and miR-155 in innate immune sensing. | Nucleic Acids Res | 2013 | https://conductscience.org/library/papers/23143100 | PubMed |
| 5 | 26692956 | MiRNA-155 mediates TAM resistance by modulating SOCS6-STAT3 signalling pathway in breast cancer. | Am J Transl Res | 2015 | https://conductscience.org/library/papers/26692956 | PubMed |
| 6 | 25977294 | DIANA-miRPath v3.0: deciphering microRNA function with experimental support. | Nucleic Acids Res | 2015 | https://conductscience.org/library/papers/25977294 | PubMed |
| 7 | 37860265 | Methods of miRNA delivery and possibilities of their application in neuro-oncology. | Noncoding RNA Res | 2023 | https://conductscience.org/library/papers/37860265 | PubMed |
| 8 | 34072348 | MicroRNA Therapeutics in Cancer: Current Advances and Challenges. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34072348 | PubMed |
| 9 | 30405848 | MicroRNA-34 family in breast cancer: from research to therapeutic potential. | J Cancer | 2018 | https://conductscience.org/library/papers/30405848 | PubMed |
| 10 | 38213224 | Correlation of miR-155-5p, KRAS, and CREB Expression in Patients with Acute Myeloid Leukemia. | Clin Lab | 2024 | https://conductscience.org/library/papers/38213224 | PubMed |
| 11 | 38584226 | Analysis of the differential expression of serum miR-21-5p, miR-135-5p, and miR-155-5p by Bifidobacterium triplex viable capsules during the perioperative stage of colorectal cancer. | Int J Colorectal Dis | 2024 | https://conductscience.org/library/papers/38584226 | PubMed |
| 12 | 35064305 | MiR-21 participates in LPS-induced myocardial injury by targeting Bcl-2 and CDK6. | Inflamm Res | 2022 | https://conductscience.org/library/papers/35064305 | PubMed |
| 13 | 28121346 | The diagnostic and prognostic values of microRNA-21 in patients with gastric cancer: a meta-analysis. | Eur Rev Med Pharmacol Sci | 2017 | https://conductscience.org/library/papers/28121346 | PubMed |
| 14 | 19074548 | MicroRNA-regulated pathways associated with endometriosis. | Mol Endocrinol | 2009 | https://conductscience.org/library/papers/19074548 | PubMed |
| 15 | 29282605 | miR-155 in cancer drug resistance and as target for miRNA-based therapeutics. | Cancer Metastasis Rev | 2018 | https://conductscience.org/library/papers/29282605 | PubMed |
| 16 | 38608633 | Evaluation of miR-155 silencing using a molecular beacon in human lung adenocarcinoma cell line. | Talanta | 2024 | https://conductscience.org/library/papers/38608633 | PubMed |
| 17 | 39128096 | LncRNA FAM30A Predicts Adverse Prognosis and Regulates Cellular Processes in Colorectal Cancer via Modulating miR-21-3p. | Turk J Gastroenterol | 2024 | https://conductscience.org/library/papers/39128096 | PubMed |
| 18 | 26852921 | Colorectal cancer characterization and therapeutic target prediction based on microRNA expression profile. | Sci Rep | 2016 | https://conductscience.org/library/papers/26852921 | PubMed |
| 19 | 39068557 | Biomarkers for Oral Squamous Cell Carcinoma (miR-24, miR-200, and miR-34): Screening and Detection MicroRNA. | Asian Pac J Cancer Prev | 2024 | https://conductscience.org/library/papers/39068557 | PubMed |
| 20 | 37210578 | Curcumin activates a ROS/KEAP1/NRF2/miR-34a/b/c cascade to suppress colorectal cancer metastasis. | Cell Death Differ | 2023 | https://conductscience.org/library/papers/37210578 | PubMed |
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42978749 | A systematic review on the possible role of microRNA-155 in cancer treatment. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42978749 | PubMed |
| 42938883 | Evaluation of the Diagnostic and Prognostic Potential, and Correlation with the Tumor Immune Microenvironment of a Six-miRNA Signature Associated with Platinum Sensitivity in Patients with Early-Stage Non-Small-Cell Lung Cancer. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42938883 | PubMed |
| 42850359 | The potential role of miR-34a and miR-34c in the regulation of pediatric high-grade glioma 4 aggressiveness. | Pediatr Res | 2026 | https://conductscience.org/library/papers/42850359 | PubMed |
| 42728899 | Expression of EBNA1 and miR-155 in Papillary Thyroid Carcinoma: A Case-Control Study in Iraqi Patients. | F1000Res | 2025 | https://conductscience.org/library/papers/42728899 | PubMed |
| 42699688 | Nanoparticle-Based miRNA Therapeutics in Breast Cancer Highlighting Design Strategies and Translational Potential. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42699688 | PubMed |
| 42694631 | Non-coding RNAs in cancer: multi-omics insights, liquid biopsy advances, drug resistance mechanisms, and the road to clinical translation. | Front Oncol | 2026 | https://conductscience.org/library/papers/42694631 | PubMed |
| 42653348 | Circulating and Tissue MicroRNA Profiles Associated with Pathological Complete Response in HER2+ Breast Cancer: A Systematic Review. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653348 | PubMed |
| 42627073 | Unlocking the potential of microRNA as predictive biomarkers for efficacy and adverse events in immune checkpoint inhibitor therapy (Review). | Mol Med Rep | 2026 | https://conductscience.org/library/papers/42627073 | PubMed |
| 42609748 | miR-1246 as a Diagnostic, Prognostic, and Therapeutic Biomarker in Breast Cancer: A Narrative Review With Pharmacoeconomic Perspectives. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/42609748 | PubMed |
| 42474758 | Acidic nuclear phosphoprotein 32A (ANP32A): structure, function, and its role in disease pathogenesis. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42474758 | PubMed |
| 42246188 | Dual targeting of mitochondrial metabolism and Rho GTPase signaling to suppress cancer metastasis (Review). | Oncol Rep | 2026 | https://conductscience.org/library/papers/42246188 | PubMed |
| 42142294 | Functional dynamics of lncRNAs and miRNAs in cancer metabolism and neuroinflammation. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42142294 | PubMed |
| 42074564 | Non-Coding RNAs in Cancer: Decoding Regulatory Networks for Liquid Biopsy Applications. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42074564 | PubMed |
| 42065054 | Integrative Machine Learning and Experimental Validation Identify MYBL2 as a Prognostic Biomarker and Therapeutic Target in Hepatocellular Carcinoma. | Oncol Res | 2026 | https://conductscience.org/library/papers/42065054 | PubMed |
| 42064118 | Assessment of miR-760 expression as a potential diagnostic biomarker in oral squamous cell carcinoma: A RT-PCR study. | J Oral Maxillofac Pathol | 2026 | https://conductscience.org/library/papers/42064118 | PubMed |
| 42014656 | The role of hydroxyurea in modulating miRNA expression in sickle cell disease: molecular mechanisms and therapeutic implications. | Ann Hematol | 2026 | https://conductscience.org/library/papers/42014656 | PubMed |
| 41901058 | The Impact of Diet on Long-Term Oncological Outcomes: Investigating Nutritional Mechanisms in Cancer Prevention Management and Prognosis. | Nutrients | 2026 | https://conductscience.org/library/papers/41901058 | PubMed |
| 41900919 | MicroRNAs in Heart Failure Pathogenesis and Progression: Mechanistic Control, Biomarker Potential, and Translational Perspectives. | Life (Basel) | 2026 | https://conductscience.org/library/papers/41900919 | PubMed |
| 41751166 | Diet-Driven Epigenetic Alterations in Colorectal Cancer: From DNA Methylation and microRNA Expression to Liquid Biopsy Readouts. | Biomedicines | 2026 | https://conductscience.org/library/papers/41751166 | PubMed |
| 41703602 | Targeting inflammatory microenvironments: overcoming therapy resistance and immunosuppression. | Mol Cancer | 2026 | https://conductscience.org/library/papers/41703602 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MIR155 | 406947 | PubTator's text mining | https://conductscience.org/library/genes/406947 | NCBI Gene |
| MIR21 | 406991 | PubTator's text mining | https://conductscience.org/library/genes/406991 | NCBI Gene |
| MIR34A | 407040 | PubTator's text mining | https://conductscience.org/library/genes/407040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39512697
GET https://conductscience.org/api/papers/v1/39512697/references?page=2